{
    "root": "313fd56f-b10b-b499-e063-6294a90a2912",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Amlodipine Besylate",
    "value": "20250326",
    "ingredients": [
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "AMLODIPINE BESYLATE",
            "code": "864V2Q084H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2668"
        }
    ],
    "indications": {
        "text": "amlodipine besylate tablets calcium channel blocker may used alone combination antihypertensive antianginal agents treatment : hypertension ( 1.1 ) amlodipine besylate tablets indicated treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . coronary artery disease ( 1.2 ) chronic stable angina vasospastic angina ( prinzmetal \u2019 variant angina ) angiographically documented coronary artery disease patients without heart failure ejection fraction < 40 %",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "coronary artery disease (DOID:3393)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3393"
            },
            {
                "text": "artery disease (DOID:0050828)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050828"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "variant angina (DOID:0111151)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0111151"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "chronic stable angina",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_458775"
            }
        ]
    },
    "contraindications": {
        "text": "adult recommended starting dose : 5 mg daily maximum dose 10 mg daily . ( 2.1 ) small , fragile , elderly patients , patients hepatic insufficiency may started 2.5 mg daily . ( 2.1 ) pediatric starting dose : 2.5 mg 5 mg daily . ( 2.2 ) important limitation : doses excess 5 mg daily studied pediatric patients . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "amlodipine besylate tablets usp available follows : 2.5 mg tablets 2.5 mg ( equivalent 2.5 mg amlodipine per tablet ) - white off-white , round , standard convex tablets , debossed number \u201c 93 \u201d one side \u201c 83 \u201d side tablet supplied follows : ndc 42291-025-10 bottles 1000 5 mg tablets 5 mg ( equivalent 5 mg amlodipine per tablet ) - white off-white , round , standard convex tablets , debossed number \u201c 93 \u201d one side \u201c 7167 \u201d side tablet supplied follows : ndc 42291-026-10 bottles 1000 10 mg tablets 10 mg ( equivalent 10 mg amlodipine per tablet ) - white off-white , round , standard convex tablets , debossed number \u201c 93 \u201d one side \u201c 7168 \u201d side tablet supplied follows : ndc 42291-027-90 bottles 90 ndc 42291-027-10 bottles 1000 storage store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp , child-resistant closure ( required ) . keep medications reach children . manufactured : avkare pulaski , tn 38478 mfg . rev . 03/22 av 06/23 ( p )",
    "adverseReactions": "amlodipine besylate tablets contraindicated patients known sensitivity amlodipine .",
    "indications_original": "Amlodipine besylate tablets are a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension ( 1.1 ) Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Coronary Artery Disease ( 1.2 ) Chronic Stable Angina Vasospastic Angina (Prinzmetal\u2019s or Variant Angina) Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%",
    "contraindications_original": "Adult recommended starting dose: 5 mg once daily with maximum dose 10 mg once daily. ( 2.1 ) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily. ( 2.1 ) Pediatric starting dose: 2.5 mg to 5 mg once daily. ( 2.2 ) Important Limitation: Doses in excess of 5 mg daily have not been studied in pediatric patients. ( 2.2 )",
    "warningsAndPrecautions_original": "Amlodipine besylate tablets USP are available as follows:\n                  \n                     2.5 mg Tablets\n                  \n                  2.5 mg (equivalent to 2.5 mg of amlodipine per tablet) - white to off-white, round, standard convex tablets, debossed with the number \u201c93\u201d on one side and \u201c83\u201d on the other side of the tablet and supplied as follows:\n                  NDC 42291-025-10 Bottles of 1000\n                  \n                     \n                  \n                  \n                     5 mg Tablets\n                  \n                  5 mg (equivalent to 5 mg of amlodipine per tablet) - white to off-white, round, standard convex tablets, debossed with the number \u201c93\u201d on one side and \u201c7167\u201d on the other side of the tablet and supplied as follows:\n                  NDC 42291-026-10 Bottles of 1000\n                  \n                  \n                     10 mg Tablets\n                  \n                  10 mg (equivalent to 10 mg of amlodipine per tablet) - white to off-white, round, standard convex tablets, debossed with the number \u201c93\u201d on one side and \u201c7168\u201d on the other side of the tablet and supplied as follows:\n                  NDC 42291-027-90 Bottles of 90 \n    NDC 42291-027-10 Bottles of 1000\n \n                  \n                  \n                     Storage\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).\n                  KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.\n                  Manufactured for: \n    AvKARE \n    Pulaski, TN 38478\n \n                  Mfg. Rev. 03/22 \n    AV 06/23 (P)",
    "adverseReactions_original": "Amlodipine besylate tablets are contraindicated in patients with known sensitivity to amlodipine.",
    "drug": [
        {
            "name": "Amlodipine Besylate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2668"
        }
    ]
}